Definitive Contract 75D30120C09551
Award Date
9/30/20
Potential Completion Date
12/31/22
Potential Value
$2M
Federal Agency
CDC Pittsburgh
Awardee
Duke University
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
PSC Category
AJ12 - General Science And Technology R&D Services; General Science And Technology; Applied Research
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30329, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
3
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Centers for Disease Control and Prevention (CDC) awarded Duke University a $2,180,450.00 Indefinite Delivery Indefinite Quantity (IDIQ) contract for the 2023 Clinical Immunization Safety Assessment (CISA) base contract. This cost-no-fee delivery order contract will provide clinical research and immunization safety assessment services to the CDC through September 27, 2026. The contract was awarded on an unrestricted basis, without any set-aside designations. As a prime contractor, Duke...
This federal contract award was issued by the Centers for Disease Control and Prevention (CDC) to Duke University for the "LEAD SITE OPTIONAL TASK 1: BABIES COVID-19 VACCINATION" as a Delivery Order under the existing Clinical Immunization Safety Assessment (CISA) indefinite delivery indefinite quantity (IDIQ) contract vehicle. The contract has a ceiling value of $970,063.00 and a period of performance through December 28, 2025. Duke University, a private university and non-profit...
This contract was awarded to Duke University by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) as a delivery order against the Safety and Healthcare Epidemiology Prevention Research Development 2016 (SHEPheRD 2016) IDIQ contract. The contract has a firm fixed price of $1,947,688.74 and a completion date of May 31, 2022. It is not set aside for any socioeconomic program. As the prime contractor, Duke University is providing clinical research and...
Duke University Office of Research Administration Division was awarded a $467,417.49 firm fixed price delivery order against the Centers for Disease Control and Prevention's (CDC) Safety and Healthcare Epidemiology Prevention Research Development 2016 (SHEPheRD 2016) indefinite-delivery/indefinite-quantity (IDIQ) multiple award contract vehicle. The delivery order is for clinical immunization safety assessment services under Domain 1-A001 VE of the SHEPheRD 2011 program. Duke will perform...
The Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh awarded Duke University a $696,799.54 firm fixed price definitive contract to fulfill FY 21 BAA TOPIC 16 requirements. As a private university and non-profit organization located in Chamblee, Georgia, Duke University will deliver requested products or services to the CDC by the completion date of August 31, 2024. No set-aside designation was used for this contract awarded under the Broad Agency...
Duke University, as prime contractor, is providing clinical research and immunization safety assessment services under a cost-no-fee delivery order valued at $489,565. This award is issued against the prime IDIQ contract held by Duke University from the Centers for Disease Control and Prevention, entitled "Phase I Clinical Trials for Development of Neurotherapeutics", with a potential value of $86 million through September 2028. No set-aside designation was used for this delivery...
This is a $1,268,329.00 delivery order contract awarded by the Centers for Disease Control and Prevention (CDC) to Duke University on January 1, 2021. The contract is part of the CDC's Clinical Immunization Safety Assessment (CISA) indefinite delivery, indefinite quantity (IDIQ) vehicle and is for the CISA COVID Pediatric Study Lead. The contract is a cost-no-fee arrangement and does not have any set-aside designations. Duke University's Office of Research Administration Division is serving as...
This is a federal contract award from the Centers for Disease Control and Prevention (CDC) to Duke University to provide clinical research and immunization safety assessment services under the indefinite delivery indefinite quantity (IDIQ) Clinical Immunization Safety Assessment (CISA) contract vehicle. The award has a ceiling value of $549,433.00 and the period of performance runs through September 29, 2020. The contract does not have a set-aside designation. As a prime contractor for the...
Duke University Office of Research Administration Division was awarded a cost-no-fee delivery order against a Clinical Immunization Safety Assessment (CISA) indefinite-delivery/indefinite-quantity (IDIQ) contract by the Centers for Disease Control and Prevention (CDC). The $8.3 million delivery order is to support pediatric trials conducted by the National Institutes of Health's National Institute of Child Health and Human Development. As the prime contractor, Duke University will provide...
Duke University's Office of Research Administration Division was awarded a cost-no-fee delivery order contract by the Department of Health and Human Services Centers for Disease Control and Prevention to provide Clinical Immunization Safety Assessment (CISA) services. This order, valued at $1,068,872.10, will be performed in Durham, North Carolina through September 2022. The contract is part of a larger IDIQ vehicle with a potential value of $86 million through September 2028. Duke University is...